Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepke

Showing results (181-190 of 316) with videos related to

Pageof 32
Sort By:
Msystems|March 5, 2024
In-depth characterization of a selection of gut commensal bacteria reveals their functional capacities to metabolize dietary carbohydrates with prebiotic potentialCassandre Bedu-Ferrari, Paul Biscarrat, Frederic Pepke, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
Chronic Respiratory Disease|June 11, 2026
Diurnal and seasonal variation in six-minute walk distance in pulmonary hypertension: Implications for clinical monitoringLucy Robertson, Katherine Bunclark, Mark Toshner, et al.
Chest|June 10, 2011
Survival in pulmonary hypertension registries: the importance of incident casesRobin Condliffe, David G Kiely, J Gerry Coghlan, et al.
Pulmonary Circulation|October 29, 2011
Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertensionElaine Soon, Natalie J Doughty, Carmen M Treacy, et al.
Clinical Sarcoma Research|January 29, 2015
Presentation and management of pulmonary artery sarcomaHan Hsi Wong, Ioannis Gounaris, Ann McCormack, et al.
Health Technology Assessment (Winchester, England)|October 30, 2009
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluationY-F Chen, S Jowett, P Barton, et al.
Life Sciences|February 14, 2016
Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertensionMark Southwood, Robert V MacKenzie Ross, Rhoda E Kuc, et al.
Echo Research and Practice|June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UKNina Karia, Daniel Murphy, Luke Howard, et al.
Microbiome|May 25, 2025
A consortium of seven commensal bacteria promotes gut microbiota recovery and strengthens ecological barrier against vancomycin-resistant enterococciAlan Jan, Perrine Bayle, Nacer Mohellibi, et al.
Pageof 32

Showing results (181-190 of 316) with videos related to

Sort By:
Pageof 32
Msystems|March 5, 2024
In-depth characterization of a selection of gut commensal bacteria reveals their functional capacities to metabolize dietary carbohydrates with prebiotic potentialCassandre Bedu-Ferrari, Paul Biscarrat, Frederic Pepke, et al.
The European Respiratory Journal|September 26, 2024
Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)Nick H Kim, Richard Channick, Marion Delcroix, et al.
Chronic Respiratory Disease|June 11, 2026
Diurnal and seasonal variation in six-minute walk distance in pulmonary hypertension: Implications for clinical monitoringLucy Robertson, Katherine Bunclark, Mark Toshner, et al.
Chest|June 10, 2011
Survival in pulmonary hypertension registries: the importance of incident casesRobin Condliffe, David G Kiely, J Gerry Coghlan, et al.
Pulmonary Circulation|October 29, 2011
Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertensionElaine Soon, Natalie J Doughty, Carmen M Treacy, et al.
Clinical Sarcoma Research|January 29, 2015
Presentation and management of pulmonary artery sarcomaHan Hsi Wong, Ioannis Gounaris, Ann McCormack, et al.
Health Technology Assessment (Winchester, England)|October 30, 2009
Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluationY-F Chen, S Jowett, P Barton, et al.
Life Sciences|February 14, 2016
Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertensionMark Southwood, Robert V MacKenzie Ross, Rhoda E Kuc, et al.
Echo Research and Practice|June 7, 2026
Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UKNina Karia, Daniel Murphy, Luke Howard, et al.
Microbiome|May 25, 2025
A consortium of seven commensal bacteria promotes gut microbiota recovery and strengthens ecological barrier against vancomycin-resistant enterococciAlan Jan, Perrine Bayle, Nacer Mohellibi, et al.
Pageof 32